These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34923428)

  • 1. A much needed metric: Defining reliable and statistically meaningful change of the oral version Symbol Digit Modalities Test (SDMT).
    Strober LB; Bruce JM; Arnett PA; Alschuler KN; DeLuca J; Chiaravalloti N; Lebkuecher A; Di Benedetto M; Cozart J; Thelen J; Cadden M; Guty E; Román CAF
    Mult Scler Relat Disord; 2022 Jan; 57():103405. PubMed ID: 34923428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology.
    Weinstock Z; Morrow S; Conway D; Fuchs T; Wojcik C; Unverdi M; Zivadinov R; Weinstock-Guttman B; Iverson GL; Dwyer M; Benedict RH
    Mult Scler; 2022 Jun; 28(7):1101-1111. PubMed ID: 34612114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new look at an old test: Normative data of the symbol digit modalities test -Oral version.
    Strober LB; Bruce JM; Arnett PA; Alschuler KN; Lebkuecher A; Di Benedetto M; Cozart J; Thelen J; Guty E; Roman C
    Mult Scler Relat Disord; 2020 Aug; 43():102154. PubMed ID: 32450507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test.
    Middleton RM; Pearson OR; Ingram G; Craig EM; Rodgers WJ; Downing-Wood H; Hill J; Tuite-Dalton K; Roberts C; Watson L; Ford DV; Nicholas R;
    J Med Internet Res; 2020 Sep; 22(9):e18234. PubMed ID: 32965240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: Lexical access speed, memory, and information processing speed independently contribute to SDMT performance.
    Sandry J; Simonet DV; Brandstadter R; Krieger S; Katz Sand I; Graney RA; Buchanan AV; Lall S; Sumowski JF
    Mult Scler Relat Disord; 2021 Jun; 51():102950. PubMed ID: 33887609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Tablet-based symbol digit modalities test for reliably assessing information processing speed in patients with stroke.
    Tung LC; Yu WH; Lin GH; Yu TY; Wu CT; Tsai CY; Chou W; Chen MH; Hsieh CL
    Disabil Rehabil; 2016 Sep; 38(19):1952-60. PubMed ID: 26860823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symbol Digit Modalities Test: Greek Normative Data for the Oral and Written Version and Discriminative Validity in Patients with Multiple Sclerosis.
    Messinis L; Bakirtzis C; Kosmidis MH; Economou A; Nasios G; Anyfantis E; Konitsiotis S; Ntoskou A; Peristeri E; Dardiotis E; Grigoriadis N; Gourzis P; Papathanasopoulos P
    Arch Clin Neuropsychol; 2021 Jan; 36(1):117-125. PubMed ID: 32385488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual and motor confounds on the symbol digit modalities test.
    Chen MH; Chiaravalloti ND; Genova HM; Costa SL
    Mult Scler Relat Disord; 2020 Oct; 45():102436. PubMed ID: 32750607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice effect in Symbol Digit Modalities Test in multiple sclerosis patients treated with natalizumab.
    Roar M; Illes Z; Sejbaek T
    Mult Scler Relat Disord; 2016 Nov; 10():116-122. PubMed ID: 27919477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The computer-based Symbol Digit Modalities Test: establishing age-expected performance in healthy controls and evaluation of pediatric MS patients.
    Bigi S; Marrie RA; Till C; Yeh EA; Akbar N; Feinstein A; Banwell BL
    Neurol Sci; 2017 Apr; 38(4):635-642. PubMed ID: 28078569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deconstructing the symbol digit modalities test in multiple sclerosis: The role of memory.
    Patel VP; Walker LAS; Feinstein A
    Mult Scler Relat Disord; 2017 Oct; 17():184-189. PubMed ID: 29055455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symbol Digit Modalities Test Variant in a Smartphone App for Persons With Multiple Sclerosis: Validation Study.
    van Oirschot P; Heerings M; Wendrich K; den Teuling B; Martens MB; Jongen PJ
    JMIR Mhealth Uhealth; 2020 Oct; 8(10):e18160. PubMed ID: 33016886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain volumetric correlates of remotely versus in-person administered symbol digit modalities test in multiple sclerosis.
    Buyukturkoglu K; Dworkin JD; Leiva V; Provenzano FA; Guevara P; De Jager PL; Leavitt VM; Riley CS
    Mult Scler Relat Disord; 2022 Dec; 68():104247. PubMed ID: 36274283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials.
    Benedict RH; Smerbeck A; Parikh R; Rodgers J; Cadavid D; Erlanger D
    Mult Scler; 2012 Sep; 18(9):1320-5. PubMed ID: 22277740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated forms, testing intervals, and SDMT performance in a large multiple sclerosis dataset.
    Fuchs TA; Gillies J; Jaworski MG; Wilding GE; Youngs M; Weinstock-Guttman B; Benedict RH
    Mult Scler Relat Disord; 2022 Dec; 68():104375. PubMed ID: 36544304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Changes in Cognitive Test Scores in Patients With Relapsing-Remitting Multiple Sclerosis: An Analysis of the DECIDE Dataset.
    Castrogiovanni N; Mostert J; Repovic P; Bowen JD; Uitdehaag BMJ; Strijbis EMM; Cutter GR; Koch MW
    Neurology; 2023 Jul; 101(1):e1-e11. PubMed ID: 37072219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental learning during rapid information processing on the symbol-digit modalities test.
    Denney DR; Hughes AJ; Elliott JK; Roth AK; Lynch SG
    Arch Clin Neuropsychol; 2015 Jun; 30(4):322-8. PubMed ID: 25857404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study.
    Filser M; Schreiber H; Pöttgen J; Ullrich S; Lang M; Penner IK
    J Neurol; 2018 Nov; 265(11):2587-2593. PubMed ID: 30171410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.